|
08.09.25 - 06:15
|
Midday Takeaway: HSI Closes Midday at 25,508, Up 90 pts; HSTI Closes Midday at 5,702, Up 15 pts; BABA Up over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, CHINA LESSO Hit New Highs (AAStocks)
|
|
At midday close, HSI rose 90 pts or 0.4% to 25,508. HSTI rose 15 pts or 0.3% to 5,702. HSCEI gained 15 pts or 0.2% to 9,072.Active Heavyweights:BABA (09988.HK) closed at $136.7, up 3.7%XIAOMI (01810.HK) closed at $54.3, up 1.2%TENCENT (00700.HK) closed at $612, up 1.1%MEITUAN (03690.HK) closed at $102.5, down 0.5%HSI & HSCEI Con......
|
|
|
26.08.25 - 14:45
|
Fosun Pharma Announces 2025 Interim Results (PR Newswire)
|
|
Enhancing Innovation Efficiency and Steadily Expanding Globally SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company,......
|
|
|
12.08.25 - 04:00
|
H Shrs: HSI Loses 82Pts at Open; BABA-W Soft; FOSUN PHARMA Rebounds (AAStocks)
|
|
Following a joint U.S.-China statement announcing a further 90-day suspension of reciprocal 24% tariffs, Hong Kong bourse opened lower as markets awaited U.S. inflation data. The HSI dipped 82 points or 0.3% to 24,824, the HSCEI dropped 30 points or 0.3% to 8,858, and the HSTECH declined 32 points or 0.6% to 5,427.For techs, BAB......
|
|
|
|
|
26.06.25 - 12:33
|
Nature′s Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock (GlobeNewswire EN)
|
|
LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions....
|
|
25.06.25 - 22:03
|
Nature′s Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock (GlobeNewswire EN)
|
|
LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”)....
|
|
16.06.25 - 15:30
|
Teva, Shanghai Fosun Partner To Develop TEV-56278 (AFX)
|
|
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Monday said that they have partnered to develop TEV-56278.Teva's TEV-56278 ut......
|
|
|
06.06.25 - 11:15
|
FOSUN PHARMA Repurchases 800K A-Shrs, Involving ~RMB20M (AAStocks)
|
|
FOSUN PHARMA (02196.HK)(600196.SH) announced that it repurchased a total of 800,300 shares of the company on the Shanghai Stock Exchange today (6th), with the price per share ranging from RMB24.92 to RMB25.14, involving a total of approximately RMB19.9988 million. ~AASTOCKS Financial NewsWebsite: www.aastocks.com...
|
|
|
12.05.25 - 07:15
|
Research: Citi Lists H-shrs w/ US Exports (Table) (AAStocks)
|
|
Stock│Forecast for Percentage of Revenue from Export to US in 2025COWELL (01415.HK)│30%ASMPT(00522.HK)│15%BYD ELECTRONIC (00285.HK)│around 25-30%.KLN (00636.HK)│15-20%AAC TECH (02018.HK)│12%FOSUN PHARMA (02196.HK)│11%SUNNY OPTICAL (02382.HK)│9%Q TECH (01478.HK)│<1%CHERVON ......
|
|
|
|
26.03.25 - 03:30
|
Fosun Pharma Announces 2024 Annual Results (PR Newswire)
|
|
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global......
|
|
|
|